In addition to the commonly studied cellular components of TIME (Fig. 1), immune modulating molecules like TGF-β1, IDO, and Artemin in the ECM have also been considered as important parts of STIE in local tumor, and to play critical roles in cancer development and cancer immunity [26–28]. The gene discussed is IDO1; the disease is cancer.